Myeloma Awareness Month

The Snowdome Foundation collaborates with world-leading blood cancer researchers to accelerate new therapies for Australian myeloma patients.

Farewell to Cathy Rhodes

In August, we fondly said farewell to a fantastic colleague, Cathy Rhodes, Head of Operations and Finance who for six years was a crucial member of our Snowdome Executive. Cathy’s enthusiasm and commitment to ensure the Snowdome office and financial management operated with great efficiency is greatly appreciated and will be missed.  Whether it was … Continued

Cilta-cel approved for public funding

Ciltacabtagene autoleucel (cilta-cel) approved for public funding by the Medical Services Advisory Committee (MSAC) for Australian patients with refractory or relapsed multiple myeloma who have had four prior lines of treatment

Making CAR-T Cell Therapy and Clinical Trials More Accessible

In laboratories around the country and the world, Australian researchers and clinicians are striving to find new blood cancer treatments to make it a curable disease for all. We are proud to support one such researcher, Queensland’s clinician scientist, Dr Siok Tey, who is recognised nationally and internationally for her work in bone marrow transplantation … Continued

International Collaboration to Fund Innovative Research into CAR T-cell Therapy and Paediatric Leukaemia

Snowdome is very proud to continue our collaboration with the prestigious Leukemia & Lymphoma Society USA and Australia’s Leukaemia Foundation to fund Australian researchers and clinicians specialising in blood cancer research. Now entering our fourth year of funding, we are delighted to announce funding for two more ground-breaking projects into treating paediatric leukaemia and CAR … Continued